☆
4.7
Editorial Material
Tearing down the walls: FDA approves next generation sequencing (NGS) assays for actionable cancer genomic aberrations
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)
导出引文
没有可用的引文
评价这篇论文
主要评分表示论文的整体质量水平。次要评分独立反映论文的优点或缺点。
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search